UVa Transplant aims to advance the studies of disease in order to provide the best medical options to patients. We are especially focused on finding a cure for Type 1 Diabetes; developing therapies for hepatitis C, hepatocellular carcinoma, and liver cancer; and supporting successful transplants.
Our development efforts include:
- A cell isolation facility that allows healthy islets (pancreatic cells) to be harvested.
- Induced pluripotent stem cells which are made from a patient’s own tissue, potentially eliminating the need for donor cells, such as in diabetic patients who need healthy pancreatic cells.
- Isolation of the antibody immunoglobulin M, which has been shown to be a factor in how well a patient’s body tolerates a transplant.
- Biomarkers to provider earlier diagnoses and identify best treatments.
- 3D printing technology that could allow for the creation of artificial organs.